Floatz logo

Therapeutic Asset Ratings

19,639 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Cyclophosphamide
Aggressive B-Cell Non-Hodgkin's Lymphoma (NHL)
Peking University People's HospitalP2BB (68)
Cyclophosphamide
Estrogen-Receptor Positive Breast Cancer
UNC Lineberger Comprehensive Cancer CenterP2BB (68)
Cyclophosphamide
B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma And Classical Hodgkin Lymphoma
University of WashingtonP2BB (68)
Cyclophosphamide
Indolent B-Cell Non-Hodgkin Lymphoma
Institute of Hematology & Blood Diseases Hospital, ChinaP2BB (68)
Cyclophosphamide
Fallopian Tube Carcinoma
Mayo ClinicP2BB (68)
Cyclophosphamide
Sarcoma
Essen BiotechP2BB (68)
Cyclophosphamide
Small Intestine Cancer
National Cancer Institute (NCI)P2BB (68)
CYCLOSPORIN A
Anaplastic Large Cell Lymphoma
Fred Hutchinson Cancer CenterP2BB (68)
Decitabine
Myelodysplastic/Myeloproliferative Neoplasm
University of WashingtonP2BB (68)
DEXAMETHASONE
Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
OHSU Knight Cancer InstituteP2BB (68)
DEXAMETHASONE
Hematopoietic and Lymphoid Cell Neoplasm
Therapeutic Advances in Childhood Leukemia ConsortiumP2BB (68)
DEXAMETHASONE
Nodal Marginal Zone B-Cell Lymphoma
Izidore Lossos, MDP2BB (68)
DEXAMETHASONE
Splenic Marginal Zone Lymphoma
Izidore Lossos, MDP2BB (68)
DEXAMETHASONE
Waldenstrom Macroglobulinemia
Christian BuskeP2BB (68)
Eloxatin
Adenocarcinoma
University of ChicagoP2BB (68)
Eloxatin
Soft Tissue Sarcoma
OHSU Knight Cancer InstituteP2BB (68)
ENFORTUMAB VEDOTIN (fully human monoclonal antibody conjugated to a cytotoxic agent monomethyl auristatin E (MMAE) targeting nectin-4)
Ureter Neoplasm
Eli Lilly and CompanyP2BB (68)
ENFORTUMAB VEDOTIN (fully human monoclonal antibody conjugated to a cytotoxic agent monomethyl auristatin E (MMAE) targeting nectin-4)
Urinary Bladder Neoplasm
Eli Lilly and CompanyP2BB (68)
Enzalutamide
Breast Carcinoma
Nuvation Bio Inc.P2BB (68)
Enzalutamide
Triple-Negative Breast Carcinoma
Nuvation Bio Inc.P2BB (68)
Epirubicin
Primary Mediastinal Large B-cell Lymphoma (PMBCL)
Seda S. ToluP2BB (68)
Epirubicin
Recurrent Fallopian Tube Carcinoma
Roswell Park Cancer InstituteP2BB (68)
ETOPOSIDE
Acute Myeloid Leukemia With Multilineage Dysplasia
Institut de Recherches Internationales ServierP2BB (68)
ETOPOSIDE
Neuroendocrine Carcinoma
National Cancer Institute (NCI)P2BB (68)
ETOPOSIDE
Plasmablastic Lymphoma
National Cancer Institute (NCI)P2BB (68)
Showing 351 to 375 of 19,639 assets
PreviousPage 15 of 786Next